George C. Ormandy
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Epilepsy research and treatment
- Bipolar Disorder and Treatment
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Neuroscience and Neuropharmacology Research 5
- Neurotransmitter Receptor Influence on Behavior 1
-
- Epilepsy research and treatment 4
- Dementia and Cognitive Impairment Research 1
- Co-authors
- Richard Scott Jope (8 shared papers)Suzanne Craft (1 shared paper)Allen D. Roses (1 shared paper)Ann M. Saunders (2 shared papers)Marcus E. Risner (1 shared paper)David A. Hosford (2 shared papers)Marina E. Zvartau-Hind (2 shared papers)O. Carter Snead (1 shared paper)
- Journals
- Brain Research (4 papers)Experimental Neurology (2 papers)Neuropharmacology (1 paper)Alzheimer s & Dementia (1 paper)The Pharmacogenomics Journal (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
George C. Ormandy
12 papers receiving 768 citations
George C. Ormandy's Hit Papers
Peers
Comparison fields: 5 of 61
- Psychiatry and Mental health 300
- Physiology 369
- Neurology 43
- Cellular and Molecular Neuroscience 84
- Pharmacology 34
Countries citing papers authored by George C. Ormandy
This map shows the geographic impact of George C. Ormandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George C. Ormandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George C. Ormandy more than expected).
Fields of papers citing papers by George C. Ormandy
This network shows the impact of papers produced by George C. Ormandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George C. Ormandy. The network helps show where George C. Ormandy may publish in the future.
Co-authors
The 13 scholars most cited alongside George C. Ormandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Hit paper breakdown → | 2006 | 597 |
| 2 | 1989 | 92 | |
| 3 | 1991 | 44 | |
| 4 | 1992 | 24 | |
| 5 | 1991 | 18 | |
| 6 | 1989 | 13 | |
| 7 | 1990 | 7 | |
| 8 | Seizures selectively impair agonist-stimulated phosphoinositide hydrolysis without affecting protein kinase C activity in rat brain. | 1992 | 5 |
| 9 | 1990 | 4 | |
| 10 | 1993 | 4 | |
| 11 | 1990 | 3 | |
| 12 | 2006 | 1 |
About George C. Ormandy
George C. Ormandy is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health, Physiology, Molecular Biology and Nuclear Energy and Engineering, having authored 12 papers that have together received 812 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Epilepsy research and treatment (4 papers), Receptor Mechanisms and Signaling (2 papers), Alzheimer's disease research and treatments (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper), Neurotransmitter Receptor Influence on Behavior (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Psychiatry and Mental health (300 citations), Physiology (369 citations), Neurology (43 citations), Cellular and Molecular Neuroscience (84 citations) and Pharmacology (34 citations). George C. Ormandy has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Richard Scott Jope, Suzanne Craft, Allen D. Roses, Ann M. Saunders, Marcus E. Risner, David A. Hosford, Marina E. Zvartau-Hind, O. Carter Snead, Ling Song and Xiaohua Li. Their work appears in journals such as Brain Research, Experimental Neurology, Neuropharmacology, Alzheimer s & Dementia and The Pharmacogenomics Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.